These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20701871)

  • 1. Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections.
    Noreddin AM; Elkhatib WF
    J Infect Public Health; 2009; 2(3):120-8. PubMed ID: 20701871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.
    Hengzhuang W; Høiby N; Ciofu O
    Methods Mol Biol; 2014; 1147():239-54. PubMed ID: 24664838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
    Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
    Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
    Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm.
    Monden K; Ando E; Iida M; Kumon H
    J Infect Chemother; 2002 Sep; 8(3):218-26. PubMed ID: 12373484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
    Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials.
    Spoering AL; Lewis K
    J Bacteriol; 2001 Dec; 183(23):6746-51. PubMed ID: 11698361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium chanel blockers in vitro.
    Elkhatib WF; Haynes VL; Noreddin AM
    J Chemother; 2009 Apr; 21(2):135-43. PubMed ID: 19423465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.
    Cao B; Christophersen L; Thomsen K; Sønderholm M; Bjarnsholt T; Jensen PØ; Høiby N; Moser C
    J Antimicrob Chemother; 2015 Jul; 70(7):2057-63. PubMed ID: 25786481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ototopical medications on tympanostomy tube biofilms.
    Oxley KS; Thomas JG; Ramadan HH
    Laryngoscope; 2007 Oct; 117(10):1819-24. PubMed ID: 17690613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
    Pompilio A; Crocetta V; Pomponio S; Fiscarelli E; Di Bonaventura G
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):318-25. PubMed ID: 26004353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
    Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N
    Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
    Pye CC; Yu AA; Weese JS
    Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.